987 related articles for article (PubMed ID: 8752246)
21. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
23. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer.
Girardi F; Petru E; Heydarfadai M; Haas J; Winter R
Gynecol Oncol; 1993 May; 49(2):177-80. PubMed ID: 8504985
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
25. Predictors of lymphatic failure in endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Aletti G; Podratz KC
Gynecol Oncol; 2002 Mar; 84(3):437-42. PubMed ID: 11855884
[TBL] [Abstract][Full Text] [Related]
26. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
Yokoyama Y; Maruyama H; Sato S; Saito Y
Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of DNA ploidy in endometrial cancer.
Larson DM; Berg R; Shaw G; Krawisz BR
Gynecol Oncol; 1999 Sep; 74(3):356-60. PubMed ID: 10479493
[TBL] [Abstract][Full Text] [Related]
29. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
[TBL] [Abstract][Full Text] [Related]
30. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
31. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
32. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
Wen HW; Zhang LD
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
[TBL] [Abstract][Full Text] [Related]
33. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
[TBL] [Abstract][Full Text] [Related]
34. Use of the sentinel node procedure to stage endometrial cancer.
Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of routine lymphadenectomy in clinical stage-I endometrial cancer.
Han SS; Cho JY; Park IA; Park SK; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Med Sci Monit; 2008 Apr; 14(4):CR183-9. PubMed ID: 18376345
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of preoperative tests in clinical stage I endometrial cancer: the importance of lymphadenectomy.
Cho H; Kim YT; Kim JH
Acta Obstet Gynecol Scand; 2010; 89(2):175-81. PubMed ID: 19943822
[TBL] [Abstract][Full Text] [Related]
37. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
38. Correlation between pretreatment prognostic factors and lymph node metastases in endometrial adenocarcinoma. Clinical application.
La Fianza A; Alberici E; Generoso P; Preda L; Campani R
Radiol Med; 2000 Nov; 100(5):363-6. PubMed ID: 11213416
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer.
Mariani A; Webb MJ; Galli L; Podratz KC
Gynecol Oncol; 2000 Mar; 76(3):348-56. PubMed ID: 10684709
[TBL] [Abstract][Full Text] [Related]
40. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
